亚太肠内喂养配方奶粉市场 – 行业趋势及 2030 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

亚太肠内喂养配方奶粉市场 – 行业趋势及 2030 年预测

  • Healthcare
  • Upcoming Report
  • Nov 2022
  • Asia-Pacific
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Asia Pacific Enteral Feeding Formula Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2030
Diagram Market Size (Base Year)
USD 0.58 Billion
Diagram Market Size (Forecast Year)
USD 1.02 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Nutricia
  • Hormel Foods Corporation
  • Medline Industries
  • Mead Johnson & Company LLC.
  • Nestlé Health Science

>亚太肠内喂养配方市场,按产品(标准配方、糖尿病配方、肾配方、肝配方、肺配方、肽基配方、其他疾病特定配方和疾病特定配方)、应用(肿瘤学、神经病学、重症监护、糖尿病、胃肠病学和其他)、管饲类型(胃管喂养、鼻胃管喂养、胃造口管喂养和十二指肠或空肠管喂养)、阶段(成人和儿科)、最终用户(医院、疗养院、辅助生活设施、家庭护理机构、临终关怀和长期护理机构)划分——行业趋势和预测到 2030 年。

亚太肠内喂养配方市场

亚太肠内喂养配方市场分析及规模

据世界卫生组织统计,近 70% 的癌症死亡发生在中低收入国家。由于慢性疾病和病症的增加、人口快速老龄化、早产率的上升、医疗费用的增加以及家庭护理需求的增加,肠内喂养配方奶粉行业正在不断扩大。

Data Bridge Market Research 分析,肠内喂养配方市场在 2022 年为 5.8 亿美元,预计到 2030 年将达到 10.2 亿美元,在 2023 年至 2030 年的预测期内复合年增长率为 7.3%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

亚太肠内喂养配方市场范围和细分

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021(可定制为 2015 - 2020)

定量单位

收入(单位:十亿美元)、销量(单位:台)、定价(美元)

涵盖的领域

产品(标准配方、糖尿病配方、肾脏配方、肝脏配方、肺部配方、肽基配方、其他疾病特定配方和疾病特定配方)、应用(肿瘤科、神经科、重症监护、糖尿病、胃肠病学和其他)管饲类型(胃管饲、鼻胃管饲、胃造口管饲和十二指肠或空肠管饲)、阶段(成人和儿童)、最终用户(医院、疗养院、辅助生活设施、家庭护理机构、临终关怀和长期护理机构)

覆盖国家

亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 其他地区

涵盖的市场参与者

Nutricia (Netherlands), Hormel Foods Corporation (U.S), Medline Industries, Inc. (U.S), Mead Johnson & Company, LLC. (U.S), Nestlé Health Science (Switzerland), Abbott (U.S), Meiji Holdings Co., Ltd. (Japan), Fresenius Kabi AG (Germany), B. Braun SE (Germany), Trovita Health Science (U.S), Victus Inc. (U.S), Avanos Medical Inc. (U.S), Cardinal Health (U.S), Moog Inc (U.S), Conmed Corporation (U.S), Cook Medical (India)

Market Opportunities

  • New product launches in the enteral feeding market
  • Growing elderly population suffering from cancer

Market Definition

Enteral tube feeding is introducing nutrients into the intestines or stomach through tubes for those unable to meet their nutritional demands or absorb nutrients orally. Tubes such as nasojejunal tubes, gastrostomy tubes, nasogastric tubes, and jejunostomy tubes are offered for enteral feed formula. The many methods for delivering the needed nutrients are cost-effective, nutritious, and a viable alternative to intrusive surgery.

Enteral Feeding Formula Market Dynamics

Drivers

  • Rise in the geriatric population and chronic diseases in them

The Asia-Pacific geriatric population is steadily growing, resulting in an increase in chronic diseases in the region. The EU-27's growing elderly population (those aged 85 and up) has several implications. The cost of providing good health and long-term care is one of the main sources of concern for the concerned authority, as extremely elderly people require proportionally more social services. Furthermore, because neurological illnesses such as multiple sclerosis, stroke, and dementia impair swallowing, the elderly population is the market's primary target consumer.

  • Expansion in product portfolio

The development of product portfolios by major market players is attributed to driving growth in the Asia-Pacific market for enteral feeding formulas. Leading pharmaceutical and nutraceutical companies invest in research and development (R&D), resulting in market-leading product discoveries. The introduction of ready-to-drink (RTD) products, ready-to-use nutritional supplements, and improved tube quality are all helping to propel the market forward.

Opportunities

  • New product launches in the enteral feeding market

In recent years, the Asia-Pacific enteral feeding market has seen new product releases. These unique product developments are a component of the market's enormous prospective opportunities. Furthermore, technological advancements and product innovations are two major factors driving the enteral feeding formula market forward. The broad product portfolios and robust product developments of key companies assist the market's expansion. Some product categories that have gained traction in recent years include ready-to-drink (RTD), ready-to-use nutritional supplements, tube feed, and tube feed for specific specialized uses.

Restraints/Challenges

  • Complications associated with enteral feeding

According to the National Center for Biotechnology Information, gastrostomy and jejunostomy feeding tubes are commonly implanted and used for long-term home enteral nutrition support. Although the insertion of these tubes is usually associated with minor morbidity, long-term use can result in various problems and diseases that can reduce the quality of life and have serious financial consequences. All these factors contribute to the region's slow expansion of the enteral feeding formula market.

This enteral feeding formula market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the enteral feeding formula market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Enteral Feeding Formula Market

According to a study published in the Society of Critical Care Medicine and the American Society for Parenteral and Enteral Nutrition, starting early enteral nutrition (EN) within 24-36 hours of ICU admission or within 12 hours of intubation and placement on automatic aeration is recommended in the treatment of COVID-19 patients. The COVID-19 outbreak is expected to impact the enteral feeding formula market because good supportive care remains the cornerstone in dealing with critically ill patients with COVID-19 infection, and nutritional management of ICU-admitted COVID-19 patients is an integral component of supportive measures.

Recent Development

  • In October 2020, Nestle Health Science launched China's first ready-to-drink protein-based total nutrition Foods for Special Medical Purposes (FSMPs) for malnourished people.
  • In June 2020, Otuska Pharmaceuitical Factory Inc. launched  Enoras Liquid, an enteral polymeric enteric nutrition.

Asia-Pacific Enteral Feeding Formula Market Scope

The enteral feeding formula market is segmented on the basis of product, stage, type of tube feeding, indication and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • Standard formula
  • Disease-specific formula
  • Diabetic Formula
  •  Renal Formula
  • Hepatic Formula
  •  Pulmonary Formula
  •  Peptide-based Formula
  • Other Disease Specific Formula

Stage

  • Adult
  • Pediatric

Indication

  • Alzheimer's
  • Nutrition Deficiency
  • Cancer Care
  • Diabetes
  • Chronic Kidney Diseases
  • 孤儿病
  • 吞咽困难
  • 疼痛管理
  • 吸收不良/胃肠道疾病/腹泻
  • 其他的

管饲类型

  • 胃管喂养
  • 鼻胃管喂养
  • 胃造口管喂养
  • 十二指肠或空肠管饲

终端用户

  • 医院
  • 心脏病学
  • 神经病学
  • 重症监护 (ICU)
  • 肿瘤学
  • 其他的
  • 家庭护理
  • 养老院
  • 辅助生活设施
  •  家庭护理机构
  •  临终关怀院

肠内喂养配方市场区域分析/见解

对肠内喂养配方市场进行了分析,并按国家、产品、阶段、管饲类型、适应症和最终用户提供了市场规模见解和趋势。

肠内喂养配方奶粉市场报告涵盖的国家包括亚太地区的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区其他地区

由于人们对早期诊断的认识不断提高,预计亚太地区将在 2023 年至 2030 年间实现增长。由于该地区早产发生率不断上升且政府的医疗保健支出不断增加,中国在亚太市场占据主导地位。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化影响了市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在对国家数据进行预测分析时,还考虑了亚太品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

竞争格局和肠内喂养配方市场份额分析

肠内喂养配方奶粉市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、亚太地区业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对肠内喂养配方奶粉市场的关注有关。

肠内喂养配方奶粉市场的一些主要参与者包括:

  • Nutricia(荷兰)
  • 荷美尔食品公司(美国)
  • Medline Industries, Inc.(美国)
  • 美赞臣公司(Mead Johnson & Company, LLC.)(美国)
  • 雀巢健康科学(瑞士)
  • 雅培(美国)
  • 明治控股株式会社(日本)
  • 费森尤斯卡比公司(德国)
  • B. Braun SE(德国)
  • Trovita Health Science(美国)
  • Victus Inc.(美国)
  • Avanos Medical Inc.(美国)
  • 康德乐 (美国)
  • Moog Inc(美国)
  • Conmed Corporation(美国)
  • 库克医疗(印度)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on Asia-Pacific Enteral Feeding Formula Market, By Product (Standard Formulas, Diabetic Formula, Renal Formula, Hepatic Formula, Pulmonary Formula, Peptide-based Formula, Other Disease Specific Formula, and Disease-Specific Formulas), Application (Oncology, Neurology, Critical Care, Diabetes, Gastroenterology, and Others), Type of Tube Feeding (Gastric Tube Feeding, Nasogastric Tube Feeding, Gastrostomy Tube Feeding, and Duodenal or Jejunal Tube Feeding), Stage (Adult and Pediatric), End User (Hospitals, Nursing Homes, Assisted Living Facilities, Home Care Agencies, and Hospices and Long Term Care Facilities) – Industry Trends and Forecast to 2030. .
The Asia Pacific Enteral Feeding Formula Market size was valued at USD 0.58 USD Billion in 2022.
The Asia Pacific Enteral Feeding Formula Market is projected to grow at a CAGR of 7.3% during the forecast period of 2023 to 2030.
The major players operating in the market include Nutricia, Hormel Foods Corporation, Medline Industries , Mead Johnson & Company LLC., Nestlé Health Science, Abbott, Meiji Holdings Co. , Fresenius Kabi AG, B. Braun SE, Trovita Health Science, Victus , Avanos Medical , Cardinal Health, Moog , Conmed Corporation, Cook Medical .
The market report covers data from the China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).